| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 04/16/2002 | US6372471 Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 04/16/2002 | US6372469 CDNA encoding plant-derived epoxide hydrolase, gene encoding same and transformant |
| 04/16/2002 | US6372468 Useful in the development of human therapeutics and diagnostic formulations |
| 04/16/2002 | US6372462 Cultivating a fungi of the basidiomycetes in a submerged culture on nutrient media, isolating the biomass of edible mushrooms from the culture broth, and drying at a range of 40-45 degrees celsius |
| 04/16/2002 | US6372459 For producing enantiomer-enriched amino acids, and derivatives |
| 04/16/2002 | US6372458 Process for the biotransformation of colchicone compounds into the correspondence 3-glycosyl derivatives |
| 04/16/2002 | US6372457 Culturing in a fermentation medium a microorganism having a genetic modification in an amino sugar metabolic pathway; recovering a product produced from culturing which is selected from glucosamine-6-phosphate and glucosamine |
| 04/16/2002 | US6372454 Also vectors, host cells; screening methods for identifying agonists or antagonists of follistatin-3 activity; diagnostic methods for detecting reproductive system and cell differentiation disorders and treating these |
| 04/16/2002 | US6372443 Cassette for expressing a toxoplasma gondii P30 protein |
| 04/16/2002 | US6372431 Mammalian toxicological response markers |
| 04/16/2002 | US6372212 Chitinase materials and methods |
| 04/16/2002 | US6372209 Vaginal lactobacillus medicant |
| 04/16/2002 | US6372207 IFNAR2/IFN complex |
| 04/16/2002 | CA2235752C Process for preparing o-acetylserine, l-cysteine and l-cysteine-related products |
| 04/11/2002 | WO2002029086A2 Nucleic acid sequences differentially expressed in cancer tissue |
| 04/11/2002 | WO2002029084A2 Industrial-scale serum-free production of recombinant factor vii in mammalian cells |
| 04/11/2002 | WO2002029083A2 Industrial-scale serum-free production of recombinant proteins in mammalian cells |
| 04/11/2002 | WO2002029078A2 Biocatalytic synthesis of shikimic acid |
| 04/11/2002 | WO2002029075A2 Multiple inducible gene regulation system |
| 04/11/2002 | WO2002029067A1 EXPRESSION VECTORS WITH MODIFIED ColE1 ORIGIN OF REPLICATION FOR CONTROL OF PLASMID COPY NUMBER |
| 04/11/2002 | WO2002029065A2 Retroviral vectors containing internal ribosomal entry sites |
| 04/11/2002 | WO2002029061A2 G-protein coupled receptors |
| 04/11/2002 | WO2002029060A2 Hematopoietin receptors hpr1 and hpr2 |
| 04/11/2002 | WO2002029059A2 Nogo receptor homologs |
| 04/11/2002 | WO2002029058A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | WO2002029055A2 Carbohydrate-associated proteins |
| 04/11/2002 | WO2002029053A1 Novel g protein-coupled receptor protein and dna thereof |
| 04/11/2002 | WO2002029045A2 Method for the production of vitamin k-dependent proteins |
| 04/11/2002 | WO2002029041A2 32146 and 57259, novel human transporters and uses thereof |
| 04/11/2002 | WO2002029040A2 25219, a novel human aminotransferase and uses therefor |
| 04/11/2002 | WO2002029038A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | WO2002029036A2 Lipid metabolism enzymes |
| 04/11/2002 | WO2002029035A2 Method to alter sugar moieties |
| 04/11/2002 | WO2002029030A2 Ethanol production |
| 04/11/2002 | WO2002029029A2 Nucleotide sequences which code for the cysd, cysn, cysk, cyse and cysh genes of c. glutamicum |
| 04/11/2002 | WO2002029025A2 Factor vii glycoforms |
| 04/11/2002 | WO2002029019A2 2.5-diketo-d-gluconic acid reductases and methods of use |
| 04/11/2002 | WO2002029016A2 Thermostable polymerase based on thermococcus pacificus |
| 04/11/2002 | WO2002029009A1 Cells engineered to contain genes of interest without drug resistance gene markers and materials and methods therefor |
| 04/11/2002 | WO2002028906A2 Regulation of human sphingosine kinase-like protein |
| 04/11/2002 | WO2002028902A2 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 04/11/2002 | WO2002028900A2 Tach: new tnf-receptor family nucleic acids and polypeptides |
| 04/11/2002 | WO2002028897A2 Human g-protein coupled receptor and uses thereof |
| 04/11/2002 | WO2002028894A1 Gene relating to drug tolerance and utilization thereof |
| 04/11/2002 | WO2002028892A1 Von willebrand factor-binding proteins from staphylococci |
| 04/11/2002 | WO2002028891A2 Listeria inocua, genome and applications |
| 04/11/2002 | WO2002028889A2 Haemophilus influenzae antigens and corresponding dna fragments |
| 04/11/2002 | WO2002028824A1 Citrullimycines, a process for their production and their use as pharmaceuticals |
| 04/11/2002 | WO2002028424A2 Kyberdrug as autovaccines with immune-regulating effects |
| 04/11/2002 | WO2002028423A1 Stabilisation of plasmid inheritance in bacteria by preventing multimerisation |
| 04/11/2002 | WO2002028419A2 Chemokine mutants in the treatment of multiple sclerosis |
| 04/11/2002 | WO2002028414A1 Compositions and methods for wt1 specific immunotherapy |
| 04/11/2002 | WO2002028351A2 Recombinant mucin binding proteins from steptococcus pneumoniae |
| 04/11/2002 | WO2002012288A3 Vaccination against host cell-associated herpesviruses |
| 04/11/2002 | WO2002009872A3 Biodehalogenating cultures and production thereof |
| 04/11/2002 | WO2002007514A3 Glycosylated vegf-b and method for increasing the amount of soluble vegf-b |
| 04/11/2002 | WO2002003911A3 Prevention and treatment of alzheimer's disease |
| 04/11/2002 | WO2002000898A9 Transformation system of fungus belonging to the genus monascus |
| 04/11/2002 | WO2002000725A3 G-protein coupled receptor org10 |
| 04/11/2002 | WO2001092308A3 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 04/11/2002 | WO2001090312A9 Ammonia-oxidizing bacteria |
| 04/11/2002 | WO2001089297A3 A bioinsecticide formulation consisting of bacillus thuringiensis var israelensis, and its concerning manufacture proceedings |
| 04/11/2002 | WO2001085935A3 Endothelial differentiation gene 6-like g protein coupled receptor |
| 04/11/2002 | WO2001083768A3 Serine-threonine kinase |
| 04/11/2002 | WO2001077148A3 Human lipid binding protein 1 |
| 04/11/2002 | WO2001074856A3 Wnt-7b-like polypeptides and nucleic acids encoding same |
| 04/11/2002 | WO2001072780A3 Polynucleotides for diagnosing mammary gland cancer |
| 04/11/2002 | WO2001070989A3 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins |
| 04/11/2002 | WO2001070174A3 Vegf-modulated genes and methods employing them |
| 04/11/2002 | WO2001068833A3 Recombinant hhv8 dna |
| 04/11/2002 | WO2001062924A3 Human g protein-coupled receptors |
| 04/11/2002 | WO2001060844A3 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 04/11/2002 | WO2001055320A3 Nucleic acids, proteins, and antibodies |
| 04/11/2002 | WO2001055316A3 Nucleic acids, proteins, and antibodies |
| 04/11/2002 | WO2001053348A3 Human polypeptides related to the vanilloid and trp families of cation channel proteins and nucleic acids encoding them |
| 04/11/2002 | WO2001051647A3 Method for increasing the content of fatty acids in plants and micro-organisms |
| 04/11/2002 | WO2001051511A3 Recombinant production of human histone-1 subtypes and use thereof for therapeutic purposes |
| 04/11/2002 | WO2000049164A9 Dna encoding a plant lipase, transgenic plants and a method for controlling senescence in plants |
| 04/11/2002 | WO2000034318A9 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof |
| 04/11/2002 | WO2000011188A9 Transgenic microbial polyhydroxyalkanoate producers |
| 04/11/2002 | US20020042932 Recombinant vector containing prokaryotic gene from bacillus or intestinal bacteria including ubiquitin promoter that targets cytosol or plastid of host plant, enhancing photosynthetic efficiency |
| 04/11/2002 | US20020042499 Novel inhibitor of the inflammatory response induced by TNF-alpha and IL-1 |
| 04/11/2002 | US20020042385 Cloning of a novel 7TM receptor AXOR-2 |
| 04/11/2002 | US20020042369 Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics |
| 04/11/2002 | US20020042137 System for generating recombinant viruses |
| 04/11/2002 | US20020042135 Kit for in transform and expression of heterologous gene in bacterial |
| 04/11/2002 | US20020042134 Modification of bacteria |
| 04/11/2002 | US20020042133 Immortalised cell line derived from normal human skin tissues |
| 04/11/2002 | US20020042119 Novel Metalloproteinases |
| 04/11/2002 | US20020042118 Isolated nucleic acid fragment encoding said proteins and chimeric microorganisms tranformed with said fragments capable of expressing phenol-induced proteins |
| 04/11/2002 | US20020042114 Novel human protein kinases |
| 04/11/2002 | US20020042110 Novel carbonyl reductase, method for producing said enzyme, DNA encoding said enzyme, and method for producing alcohol using said enzyme |
| 04/11/2002 | US20020042104 Generation of preferential compounds in culture; obtain genetically engineered microorganism, culture, recover preferential compounds |
| 04/11/2002 | US20020042103 Process for the preparation of pseudomonic acid a antibiotic by microbiological method |
| 04/11/2002 | US20020042101 Nucleotide sequences which code enzymatic polypeptide for use in the treatment of cancer, restenosis and diabetic neuropathy |
| 04/11/2002 | US20020042097 Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues |
| 04/11/2002 | US20020042093 Polypeptide; for use in diagnosis, treatment or prevention of thyroid tumors and defects |
| 04/11/2002 | US20020042044 Cells of Dictyostelium discoideum are contacted with candidate agents and the expression of genes in the Nucleotide Excision Repair and Base Excision Repair pathways are examined |
| 04/11/2002 | US20020041917 Process for mycelial culture using grain, product thereof and use the same |
| 04/11/2002 | US20020041895 Controlling particle size; foring liposomes, freeze drying, rehydration |